- Home
- DNTH vs HCKT Comparison
DNTH vs HCKT Comparison
Compare DNTH & HCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- HCKT
- Stock Information
- Founded
- DNTH 2015
- HCKT 1991
- Country
- DNTH United States
- HCKT United States
- Employees
- DNTH N/A
- HCKT N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- HCKT Professional Services
- Sector
- DNTH Health Care
- HCKT Consumer Discretionary
- Exchange
- DNTH Nasdaq
- HCKT Nasdaq
- Market Cap
- DNTH 651.8M
- HCKT 636.1M
- IPO Year
- DNTH N/A
- HCKT 1998
- Fundamental
- Price
- DNTH $20.74
- HCKT $20.27
- Analyst Decision
- DNTH Strong Buy
- HCKT Strong Buy
- Analyst Count
- DNTH 8
- HCKT 3
- Target Price
- DNTH $53.00
- HCKT $29.67
- AVG Volume (30 Days)
- DNTH 326.6K
- HCKT 329.7K
- Earning Date
- DNTH 08-07-2025
- HCKT 08-05-2025
- Dividend Yield
- DNTH N/A
- HCKT 2.37%
- EPS Growth
- DNTH N/A
- HCKT N/A
- EPS
- DNTH N/A
- HCKT 0.59
- Revenue
- DNTH $4,854,000.00
- HCKT $309,265,000.00
- Revenue This Year
- DNTH N/A
- HCKT $6.06
- Revenue Next Year
- DNTH N/A
- HCKT $5.46
- P/E Ratio
- DNTH N/A
- HCKT $34.25
- Revenue Growth
- DNTH 17.87
- HCKT 3.98
- 52 Week Low
- DNTH $13.37
- HCKT $19.39
- 52 Week High
- DNTH $32.27
- HCKT $34.02
- Technical
- Relative Strength Index (RSI)
- DNTH 53.56
- HCKT 28.62
- Support Level
- DNTH $18.08
- HCKT $20.21
- Resistance Level
- DNTH $21.18
- HCKT $21.40
- Average True Range (ATR)
- DNTH 1.50
- HCKT 0.73
- MACD
- DNTH -0.10
- HCKT -0.16
- Stochastic Oscillator
- DNTH 59.38
- HCKT 20.32
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About HCKT Hackett Group Inc (The).
The Hackett Group Inc is an IP platform-based Generative Artificial Intelligence (Gen AI) strategic consulting and executive advisory digital transformation firm. The Hackett Group provides dedicated expertise in Gen AI-enabled enterprise transformation services across the front, mid and back office areas, including its highly recognized Oracle, SAP, OneStream and Coupa implementation offerings. It operates in three segments Oracle Solutions, SAP Solutions, and Global S&BT. It generates the majority of its revenue from the Global S&BT segment in the United States.